Table 2

Baseline serum hs-CRP concentration quartiles and subsequent development or progression of diabetic nephropathy

hs-CRP quartilesNumber of subjectsPerson-yearsNumber of outcomesIncidence ratio (95% CI)*
Development of diabetic nephropathy
 First quartile485445.151114.6 (87.1–150.7)
 Second quartile252227.034149.8 (107.0–209.6)
 Third quartile357328.763191.7 (149.7–245.4)
 Fourth quartile291266.749183.7 (138.9–243.1)
Progression of diabetic nephropathy
 First quartile334309.62787.2 (59.8–127.1)
 Second quartile202188.81158.2 (32.3–105.2)
 Third quartile293269.930111.1 (77.7–159.0)
 Fourth quartile304281.529103.0 (71.6–148.3)
  • *Incidence rate of outcomes per 1,000 person-years.